MigVax-101

MigVax-101
Vaccine description
TargetSARS-CoV-2
Vaccine typeVirus-like particles
Clinical data
Routes of
administration		Oral

MigVax-101 is a COVID-19 vaccine candidate developed by Oravax Medical.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.